Cti tracker

The Contraceptive Technology Innovation Tracker—CTI Tracker—houses information on potential contraceptive leads in early development, products in pre-clinical and clinical development, and products with single-country regulatory approval. The Tracker reports on both active development platforms and inactive R&D.

Contraceptive Pipeline Baseline Report ⬇ Export Database

For more information about contraceptive R&D, visit our partner databases

Show Filters
Active
Last updated: January 7, 2026
Justicia Gendarussa Extract

Gendarussa, Gendarusin A

Active
Last updated: January 7, 2026
Injectable Bioresorbable Subcutaneous Contraceptive

mdc-WWM

Active
Last updated: January 7, 2026
Inh-172 Vaginal Non-Hormonal Contraceptive

Cystic Fibrosis Transmembrane Conductance Regulator Inhibitor

Inactive
Last updated: January 7, 2026
Indenopyridine Derivatives

l-CDB-4022, RTI-4587-073(l)

Active
Last updated: January 7, 2026
Hormone-Loaded Electrospun Mesh
Active
Last updated: January 7, 2026
GELdom Condom
Active
Last updated: January 7, 2026
Fiona LNG IUS
Inactive
Last updated: January 7, 2026
FibroPlant LNG IUS

Frameless LNG IUS

Inactive
Last updated: January 7, 2026
Femilis LNG IUS